Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer

NCT00230399 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Celecoxib
DRUG: Capecitabine
DRUG: Irinotecan

Sponsor

University of Michigan Rogel Cancer Center